Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07122206) titled 'Monitoring the Response of Combination Ursodiol and Seladelpar Treatment' on Aug. 7.

Study Type: Observational

Primary Sponsor: Methodist Health System

Condition: Primary Biliary Cholangitis

Intervention: Procedure: Blood Draws

Recruitment Status: Not recruiting

Date of First Enrollment: August 2025

Target Sample Size: 100

To know more, visit https://clinicaltrials.gov/ct2/show/NCT07122206

Published by HT Digital Content Services with permission from Health Daily Digest....